Ventricular Assist Devices & Artificial Hearts
Customize your policy alerts
Sign up for priority health Policy NO. 91509 alerts
Get alerted when Policy NO. 91509 changes without checking for updates manually.
Monitor payer policy activity
This policy defines medical necessity, coverage stance, and coding for ventricular assist devices (VADs) and total artificial hearts (TAH) for Priority Health members, including LVADs, RVADs, percutaneous devices, and TAH used as bridge-to-transplant or destination therapy.
Insertion of an extracorporeal left ventricular assist device is considered medically necessary when the applicable InterQual® criteria are met.
Insertion of an intracorporeal left ventricular assist device is considered medically necessary when the applicable InterQual® criteria are met.
Coverage Criteria for VADs and TAH
Left Ventricular Assist Devices (LVADs)
Insertion of LVAD (by type) is considered medically necessary when applicable criteria are met.
Extracorporeal and intracorporeal insertion are considered medically necessary when the applicable InterQual® criteria are met; percutaneous LVADs are considered medically necessary only for FDA‑approved indications and are experimental/investigational for other indications.
Percutaneous Right Ventricular Assist Devices (RVADs)
Percutaneous RVADs considered medically necessary under specified conditions.
Total Artificial Hearts (TAH)
Total artificial heart (TAH) coverage depends on intended use.
Authorization requests should be submitted on the Solid Organ Transplant prior authorization form.
Medically Necessary Indications — InterQual®
Covered when InterQual® criteria are met.
See Summary of Changes.
See Summary of Changes.
Real-time at-home or remote monitoring of vital signs (for example, INR, blood pressure, weight, temperature, or oxygen saturation) using Bluetooth-enabled or similarly enhanced meters, cuffs, scales, thermometers, pulse oximeters, or like devices is not medically necessary. Priority Health will not reimburse additional costs associated with these enhanced connectivity features over conventional instruments that do not include such enhancements.
Insertions of percutaneous left ventricular assist devices (e.g., TandemHeart, Impella) are considered medically necessary only for FDA‑approved indications. Use of percutaneous LVADs for indications other than those approved by the FDA is considered experimental and investigational due to insufficient evidence in the peer‑reviewed literature.
Coverage determinations for experimental, investigational, or unproven treatments are excluded except when an individual case review allows an exception. Requests for individual consideration require prior plan approval and will be reviewed by a Priority Health medical director or clinical pharmacist; exceptions may be considered for terminal illness or chronic, life‑threatening, severely disabling conditions causing serious clinical deterioration.
Enhanced remote or home vital‑sign monitoring devices (for example, Bluetooth‑enabled meters, cuffs, scales, thermometers, and pulse oximeters) are considered not medically necessary when the enhancement is limited to connectivity or convenience features rather than clinically necessary functionality.
Aside from the items explicitly listed as not medically necessary (enhanced remote/home vital‑sign monitoring devices) and the investigational status of certain device uses, there are no additional specific not medically necessary items called out in this portion of the policy.
CPT, HCPCS, and ICD-10 Codes
| 33927 | Implantation of a total replacement heart system (artificial heart) with recipient cardiectomy |
| 33928 | Removal and replacement of total replacement heart system (artificial heart) |
| 33929 | Removal of a total replacement heart system (artificial heart) for heart transplantation (List separately in addition to code for primary procedure) |
| 33975 | Insertion of ventricular assist device; extracorporeal, single ventricle |
| 33976 | Insertion of ventricular assist device; extracorporeal, biventricular |
| 33977 | Removal of ventricular assist device; extracorporeal, single ventricle |
| 33978 | Removal of ventricular assist device; extracorporeal, biventricular |
| 33979 | Insertion of ventricular assist device, implantable intracorporeal, single ventricle |
| 33980 | Removal of ventricular assist device, implantable intracorporeal, single ventricle |
| 33981 | Replacement of extracorporeal ventricular assist device, single or biventricular, pump(s), single or each pump |
| 33990 | Insertion of ventricular assist device, percutaneous including radiological supervision and interpretation; arterial access only |
| 33991 | Insertion of ventricular assist device, percutaneous including radiological supervision and interpretation; left heart, both arterial and venous access, with transseptal puncture |
| 33992 | Removal of percutaneous left ventricular assist device, arterial or arterial and venous cannula(s), at separate and distinct session from insertion |
| 33993 | Repositioning of percutaneous right or left ventricular assist device with imaging guidance at separate and distinct session from insertion |
| 33995 | Insertion of ventricular assist device, percutaneous, including radiological supervision and interpretation; right heart, venous access only |
| 33997 | Removal of percutaneous right heart ventricular assist device, venous cannula, at separate and distinct session from insertion |
| 93750 | Interrogation of ventricular assist device (VAD), in person, with physician analysis of device parameters, review of device function, with programming, if performed, and report |
| I11.0 - I11.9 | Hypertensive heart disease |
| I13.0 - I13.2 | Hypertensive heart and chronic kidney disease |
| I21.01 - I21.A9 | Acute myocardial infarction |
| I22.0 - I22.9 | Subsequent ST elevation and non-ST elevation myocardial infarction |
| I23.0 - I23.8 | Certain current complications following STEMI and NSTEMI |
| I42.0 - I42.9 | Cardiomyopathy |
| I50.1 - I50.9 | Heart failure |
| R57.0 | Cardiogenic shock |
| T82.221A - T82.228S | Mechanical complication of biological heart valve graft |
| T82.512A - T82.512S | Breakdown (mechanical) of artificial heart |
| 33927 | Implantation of a total replacement heart system (artificial heart) with recipient cardiectomy |
| 33928 | Removal and replacement of total replacement heart system (artificial heart) |
| 33929 | Removal of a total replacement heart system (artificial heart) for heart transplantation (List separately in addition to code for primary procedure) |
| 33975 | Insertion of ventricular assist device; extracorporeal, single ventricle |
| 33976 | Insertion of ventricular assist device; extracorporeal, biventricular |
| 33977 | Removal of ventricular assist device; extracorporeal, single ventricle |
| 33978 | Removal of ventricular assist device; extracorporeal, biventricular |
| 33979 | Insertion of ventricular assist device, implantable intracorporeal, single ventricle |
| 33980 | Removal of ventricular assist device, implantable intracorporeal, single ventricle |
| 33981 | Replacement of extracorporeal ventricular assist device, single or biventricular, pump(s), single or each pump |
| 33990 | Insertion of ventricular assist device, percutaneous including radiological supervision and interpretation; arterial access only |
| 33991 | Insertion of ventricular assist device, percutaneous including radiological supervision and interpretation; left heart, both arterial and venous access, with transseptal puncture |
| 33992 | Removal of percutaneous left ventricular assist device, arterial or arterial and venous cannula(s), at separate and distinct session from insertion |
| 33993 | Repositioning of percutaneous right or left ventricular assist device with imaging guidance at separate and distinct session from insertion |
| 33995 | Insertion of ventricular assist device, percutaneous, including radiological supervision and interpretation; right heart, venous access only |
| 33997 | Removal of percutaneous right heart ventricular assist device, venous cannula, at separate and distinct session from insertion |
| 93750 | Interrogation of ventricular assist device (VAD), in person, with physician analysis of device parameters, review of device function, with programming, if performed, and report |
| L8698 | Miscellaneous component, supply or accessory for use with total artificial heart system |
| Q0477 | Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only |
| Q0478 | Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type |
| Q0479 | Power module for use with electric or electric/pneumatic ventricular assist device, replacement only |
| Q0480 | Driver for use with pneumatic ventricular assist device, replacement only |
| Q0481 | Microprocessor control unit for use with electric ventricular assist device, replacement only |
| Q0482 | Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only |
| Q0483 | Monitor/display module for use with electric ventricular assist device, replacement only |
| Q0484 | Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only |
| Q0485 | Monitor control cable for use with electric ventricular assist device, replacement only |
| 33967 | Insertion of intra-aortic balloon assist device, percutaneous |
| 33968 | Removal of intra-aortic balloon assist device, percutaneous |
| 33970 | Insertion of intra-aortic balloon assist device through the femoral artery, open approach |
| 33971 | Removal of intra-aortic balloon assist device including repair of femoral artery, with or without graft |
| 33973 | Insertion of intra-aortic balloon assist device through the ascending aorta |
| 33974 | Removal of intra-aortic balloon assist device from the ascending aorta, including repair of the ascending aorta, with or without graft |
| 92970 | Cardioassist-method of circulatory assist; internal |
| 92971 | Cardioassist-method of circulatory assist; external |
Provider Actions, Prior Authorization, and Documentation
Prior Authorization Required for Implantation and Related Services
Prior authorization is required for implantation procedures and related services unless otherwise specified. Providers must obtain prior authorization prior to scheduling implantations (e.g., intracorporeal VAD insertion, total artificial heart implantation) and related services except for removal or repositioning when performed as a separate service, or for interrogation services which do not require prior authorization.
- Applies to implantable VADs and total artificial hearts listed under CPT codes in this policy.
- Exemption: removal/repositioning performed as a separate service and interrogation services do not require prior authorization.
Prior Authorization for Miscellaneous Implanted VAD Supplies (Q0508)
HCPCS Q0508 (miscellaneous supply or accessory for use with an implanted ventricular assist device) requires prior authorization. Prior authorization is required when charges for replacement device, supplies, and components exceed $1,000 for commercial members and $500 for Medicaid members. Note that device and all supplies for the initial unit are included in the inpatient (IP) stay.
- Q0508 — Miscellaneous supply or accessory for use with an implanted VAD: Prior authorization required.
- Prior auth threshold: > $1,000 (commercial), > $500 (Medicaid).
- Initial device and supplies included in the inpatient stay; do not bill separately for initial unit when included in IP stay.
Advance Care Planning Assessment Required
Providers must include an advance care planning assessment with requests for VAD or total artificial heart (TAH) services. The assessment must be completed by a qualified provider and should accompany the authorization request.
- Assessment required for members receiving VADs or artificial hearts (pre- or post-operative).
- Use Appendix A template as applicable and include with prior authorization submission.
TAH Authorization Form
Requests for total artificial heart (TAH) as bridge-to-transplant should be submitted using the Solid Organ Transplant prior authorization form.
- Use the Solid Organ Transplant prior authorization form for TAH bridge-to-transplant requests.
Medical Necessity Documentation and Individual Case Review
Providers must submit documentation demonstrating medical necessity for all prior authorization requests. Individual case review may allow coverage of investigational treatments in select circumstances (e.g., terminal illness or severe, progressive disease causing serious clinical deterioration); such requests require prior plan approval and review by a Priority Health medical director or clinical pharmacist.
- Submit clinical records, diagnostic tests, InterQual® criteria if applicable, and advance care planning assessment to support medical necessity.
- Requests for investigational or unproven treatments require prior approval and will be reviewed on an individual case basis.
Benefit and Eligibility Verification
Coverage is subject to the member's specific benefits and any applicable group-specific policy. Eligibility and benefit determinations will be made based on the member's plan in effect on the date services are rendered.
- Verify member eligibility and benefits prior to requesting authorization.
- Group-specific plan provisions may supersede this medical policy.
Prior Authorization and Investigational Treatments — Denial Risk
Failure to obtain required prior authorization may result in denial of payment. Prior authorization is also required for requests seeking coverage of investigational treatments; failure to obtain plan approval for investigational or unproven therapies may result in noncoverage.
- Obtain prior authorization before rendering services that require it to avoid claim denials.
- Requests for investigational treatments require prior plan approval.
Background
Ventricular assist devices (VADs) and total artificial hearts (TAH) provide mechanical circulatory support for patients with severe cardiac dysfunction. These devices may be used as a bridge to transplant for patients awaiting heart transplantation, as temporary support for cardiac recovery in reversible dysfunction, or as destination (permanent) therapy for select patients with end‑stage heart failure not eligible for transplant. LVADs assist the left ventricle, RVADs assist the right ventricle, and TAHs replace both ventricles. Management of patients with VADs or TAH requires a coordinated, multidisciplinary program with experienced clinicians and appropriate institutional capabilities.
Definitions
Policy Revision History
Added material statements that insertion of extracorporeal and intracorporeal left ventricular assist devices (LVADs) is considered medically necessary when applicable InterQual® criteria are met.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.